| Date | Time | Source | Headline | Symbol | Company |
| 04/10/2019 | 07:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 24/09/2019 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 24/09/2019 | 07:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 24/09/2019 | 07:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 14/09/2019 | 07:19 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 28/08/2019 | 00:03 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 17/08/2019 | 07:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 15/08/2019 | 07:12 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 15/08/2019 | 06:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/07/2019 | 23:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/07/2019 | 23:58 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/07/2019 | 07:21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 19/07/2019 | 04:12 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 18/07/2019 | 07:27 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 17/07/2019 | 06:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 13/07/2019 | 07:24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 12/07/2019 | 07:30 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 12/07/2019 | 07:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 11/07/2019 | 07:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 11/07/2019 | 07:19 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/07/2019 | 07:26 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 04/07/2019 | 06:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 04/07/2019 | 06:05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 04/07/2019 | 00:00 | GlobeNewswire Inc. | Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 03/07/2019 | 07:04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/06/2019 | 00:28 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/06/2019 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/06/2019 | 07:16 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 04/06/2019 | 07:22 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/05/2019 | 07:17 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |